Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Leukemia|July 17, 1998
Cellular resistance mechanisms with impact on the therapy of multiple myelomaF Gieseler, V NüsslerLeukemia|January 22, 1998
Cellular resistance mechanisms with impact on the therapy of multiple myelomaF Gieseler, V NüsslerEuropean Journal of Medical Research|September 11, 2001
Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?H R Salih, V NüsslerInternational Journal of Clinical Pharmacology and Therapeutics|December 7, 2002
4-1 BB ligand--just another costimulating molecule?H R Salih, P A Kiener, V NüsslerCancer Chemotherapy and Pharmacology|January 1, 1990
Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acidA Schalhorn, M Kühl, G Stupp-Poutot, et al.International Journal of Clinical Pharmacology and Therapeutics|February 26, 1998
Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell deathF Gieseler, V Nüssler, T Brieden, et al.Annals of Hematology|January 1, 1994
Cytotoxicity of anthracyclines: correlation with cellular uptake, intracellular distribution and DNA bindingF Gieseler, H Biersack, T Brieden, et al.Anticancer Research|July 1, 1997
Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myelomaS Poley, P Stieber, V Nüssler, et al.Anticancer Research|July 1, 1997
Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myelomaS Poley, P Stieber, V Nüssler, et al.European Journal of Haematology|July 1, 1990
Clinical, biochemical and cytokinetic parameters for distinguishing smouldering and rapidly proliferating variants of acute leukaemiaV Nüssler, H Sauer, R Pelka-Fleischer, et al.Pageof 3